awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37788248-1E35D8FD-A970-4E60-8BAC-F8143C61CAAB
Q37788248-1E35D8FD-A970-4E60-8BAC-F8143C61CAAB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37788248-1E35D8FD-A970-4E60-8BAC-F8143C61CAAB
Biological considerations and clinical applications of new HER2-targeted agents.
P2860
Q37788248-1E35D8FD-A970-4E60-8BAC-F8143C61CAAB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37788248-1E35D8FD-A970-4E60-8BAC-F8143C61CAAB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6fd5e86ab6650139bfcd5fde7967283092dd2e2b
P2860
Lapatinib plus capecitabine for HER2-positive advanced breast cancer.